Recent XENE News
- Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/16/2024 12:30:00 PM
- Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/04/2024 08:01:00 PM
- Xenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS Days • GlobeNewswire Inc. • 03/12/2024 08:01:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 11:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:31:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:28:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:27:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 12:04:19 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 12:03:52 AM
- Xenon Pharmaceuticals to Present at Leerink Partners Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:10:54 PM
- Xenon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 02/29/2024 09:01:00 PM
- Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update • GlobeNewswire Inc. • 02/22/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 02:12:03 PM
- Xenon Pharmaceuticals Outlines Key Milestone Opportunities for 2024 • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Xenon Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:41:00 PM
- Xenon Pharmaceuticals Announces Closing of $345.0 Million Upsized Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 12/04/2023 09:16:53 PM
- Xenon Pharmaceuticals Provides Updates on Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2023) • GlobeNewswire Inc. • 12/02/2023 05:01:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/30/2023 09:18:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 09:15:24 PM
- Xenon Pharmaceuticals Announces Pricing of Upsized $300.0 Million Public Offering • GlobeNewswire Inc. • 11/30/2023 03:51:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/29/2023 10:05:41 PM
- Xenon Pharmaceuticals Announces Proposed Public Offering • GlobeNewswire Inc. • 11/29/2023 09:03:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 12:03:57 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM